Weed Withdrawal Medication: What a Doctor Can Offer

There is no approved weed withdrawal medication. NIDA states plainly that there are currently no FDA-approved medications for the treatment of cannabis use disorder or for medically assisted withdrawal. Several drugs have been tested, and a few showed real effects in single trials, but none has enough evidence behind it to become a standard treatment.

That does not mean a doctor has nothing to offer. It means what they offer is narrower than people hope: help with one symptom at a time, usually sleep, for a short stretch, alongside the things that actually carry the weight. This article walks through what has been tried, what the trials found, and how to have the conversation.

Why there is no approved medication yet

Cannabis withdrawal is real and it is common in heavy users. According to a 2022 clinical review, symptoms typically start 24–48 hours after stopping and most peak at days 2–6, with some lasting three weeks or more in heavy users. Sleep problems may continue for several weeks or longer. The day-by-day withdrawal timeline covers what usually arrives when.

The problem is not a lack of trying. A Cochrane review of the field included 21 randomised trials involving 1,755 participants and concluded that antidepressants, bupropion, buspirone and atomoxetine are probably of little value, and that THC preparations should still be considered experimental. The trials that did show benefit were mostly small, single studies that have not been replicated at scale.

So the honest summary is this: some medications have moved withdrawal scores or sleep in a trial, none has cleared the bar for approval, and anything a doctor prescribes for this is off-label.

The medications that have been tested

Here is what the main trials found, in plain terms. Treat this as background for a conversation with a prescriber, not a menu. Every one of these drugs has side effects and interactions that a website cannot weigh for you.

Gabapentin

Gabapentin has the most encouraging single result. In a 12-week trial, 50 adults received gabapentin at 1,200 mg a day or placebo. Compared with placebo, gabapentin reduced cannabis use on urine tests and self-report, and significantly decreased withdrawal symptoms. The authors also reported that sleep disturbance improved.

It was billed as a proof-of-concept study. Fifty people is a starting point, not a verdict, and gabapentin has its own misuse potential that a prescriber will want to weigh.

N-acetylcysteine

NAC is the clearest example of why one trial is not enough. In teenagers and young adults aged 15 to 21, participants taking NAC had more than twice the odds of a negative urine test compared with placebo. A larger follow-up in 302 adults found almost nothing: 22.3% of urine tests were negative on NAC against 22.4% on placebo. The authors concluded there is no evidence it works for adults.

Cannabinoid medicines

The logic here is the same as nicotine patches: replace the smoked drug with a controlled dose and step it down. In a 128-person trial of nabiximols, a mouth spray containing THC and CBD, the placebo group used cannabis on 53.1 days over 12 weeks against 35.0 days on nabiximols.

Dronabinol, a synthetic THC capsule, is a mixed picture. In a trial of 156 adults, it lowered withdrawal symptoms and kept more people in treatment, but the share who managed two weeks of abstinence was no different: 17.7% on dronabinol against 15.6% on placebo. It made the stop easier to sit through without making stopping more likely.

None of this is a case for easing off with dispensary gummies or CBD oil. Those products are not dosed or monitored like a trial drug. The evidence on CBD specifically is covered in does CBD help with weed withdrawal.

Sleep medication

Sleep is the symptom people most often take to a doctor, and it is the one with the most targeted evidence. In a small crossover study of 20 daily users, extended-release zolpidem normalised sleep efficiency during abstinence but did not change how long it took to fall asleep. The 2022 review notes that it made no difference to overall withdrawal scores. In a lab study, mirtazapine improved sleep and increased food intake but had no effect on withdrawal symptoms and did not decrease relapse.

That pattern repeats across the field. Medication can help one symptom. It does not shorten withdrawal or make you less likely to go back.

What a doctor is likely to actually do

The 2022 review describes current practice directly: supportive counselling and psychoeducation are the first-line approaches in managing cannabis withdrawal. In clinical practice, short-term medications are sometimes added for specific symptoms such as sleep, nausea, anxiety or appetite, to make the stretch more bearable.

In practice, a visit about this usually covers:

• How much and how long you have been using, because that predicts how rough withdrawal is likely to be.
• Other substances, especially alcohol and benzodiazepines, which change the safety picture entirely.
• Mental health, since anxiety or depression that was there before cannabis can resurface once it is gone.
• One or two symptoms worth treating, most often sleep, for a defined period.
• A referral, for counselling or a structured programme, if you want one.

For the behavioural side, NIDA notes that cognitive behavioural therapy, motivational enhancement therapy and contingency management can be effective for cannabis use disorder. That is where the evidence is strongest. CBT for quitting weed explains what a course looks like, and choosing a treatment programme covers the options if you want more structure.

If you are not sure how to raise it, talking to your doctor about quitting weed has a short script and what to bring.

What you can do without a prescription

A second review of cannabis withdrawal lists what supportive care looks like without drugs, including psychoeducation, non-pharmacological symptom management, and occupational and exercise therapy. In everyday terms:

• Know the shape. Withdrawal usually peaks in the first week and eases over the following two. Knowing that day four is a peak, not a new normal, is itself a kind of treatment.
• Protect sleep with basics. Same wake time daily, caffeine before noon, no screens in bed. Expect vivid dreams for a while.
• Eat on a schedule. Appetite often drops early. Small, regular meals work better than waiting to feel hungry.
• Have a plan for cravings. Most pass in minutes. A walk, a shower, a breathing drill, anything you can do on the spot.
• Tell someone at home. If you live with someone who still uses, quitting when your partner smokes covers how to set that up.

When withdrawal needs medical help now

Cannabis withdrawal on its own is uncomfortable rather than dangerous for most people. Some situations change that, and they are the ones where seeing a clinician is not optional:

• You also drink heavily or use benzodiazepines. Withdrawal from those can be dangerous, and stopping several substances at once needs a plan. Quitting weed when you use other substances too goes into this.
• You are pregnant.
• You have hallucinations, severe paranoia or confusion.
• You have a mental health condition that is getting worse, or thoughts of harming yourself.
• You have persistent vomiting, which can signal cannabinoid hyperemesis.
• Symptoms are severe or are not easing after two to three weeks.

In the US, SAMHSA's National Helpline is free, confidential and open 24/7 at 1-800-662-4357, and SAMHSA's FindTreatment.gov lists treatment services near you. If you are in immediate danger, call your local emergency number.

Please do not borrow someone else's prescription or self-medicate with sleeping pills or alcohol to get through the first week. The trials above were run with monitoring for a reason, and swapping one dependence for another is a common way these weeks go wrong.

The honest bottom line

No pill makes quitting weed easy, and anyone selling one is ahead of the evidence. What medication can sometimes do is take the edge off one symptom, usually sleep, for a couple of weeks. The rest is the plan you make for the evenings, the support you line up, and time. Withdrawal peaks and passes in days. That part happens with or without a prescription.

Sources

• NIDA — Cannabis (Marijuana) — no FDA-approved medications; behavioural treatments
• Clinical management of cannabis withdrawal — onset, peak and duration; first-line counselling; symptomatic medication
• Pharmacotherapies for cannabis dependence (Cochrane) — 21 trials, 1,755 participants; insufficient evidence
• Gabapentin for cannabis-dependent adults: a proof-of-concept trial — 50 adults, 1,200 mg a day
• N-acetylcysteine in cannabis-dependent adolescents — odds ratio 2.4 for negative tests
• N-acetylcysteine for cannabis use disorder in adults — 22.3% vs 22.4% negative tests
• Nabiximols for the treatment of cannabis dependence — 35.0 vs 53.1 days of use
• Dronabinol for the treatment of cannabis dependence — withdrawal and retention improved; abstinence unchanged
• Extended-release zolpidem during cannabis withdrawal — sleep efficiency normalised
• Baclofen and mirtazapine in a laboratory model of withdrawal — sleep and appetite, not relapse
• The cannabis withdrawal syndrome: current insights — supportive and non-drug management
• FindTreatment.gov (SAMHSA) — treatment locator; SAMHSA National Helpline 1-800-662-4357